# Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

> **NCT02176356** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 116 (actual)

## Conditions studied

- Facial Rhytides
- Crow's Feet Lines
- Glabellar Lines
- Nasolabial Fold

## Interventions

- **BIOLOGICAL:** onabotulinumtoxinA
- **DRUG:** bimatoprost ophthalmic solution 0.03%
- **DEVICE:** JUVÉDERM® ULTRA XC
- **DEVICE:** JUVÉDERM® ULTRA PLUS XC
- **DEVICE:** JUVÉDERM® VOLUMA® XC

## Key facts

- **NCT ID:** NCT02176356
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-30
- **Primary completion:** 2015-05-03
- **Final completion:** 2015-05-03
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176356, "Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02176356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*